Immunoreconstitution
Showing 1 - 19 of 19
Poor Thymic Function, Immunodeficiency, Athymia Trial (biological, procedure, drug)
Approved for marketing
- Poor Thymic Function
- +5 more
- Cultured Thymus Tissue
- +2 more
- (no location specified)
Mar 23, 2022
Acute Lymphoblastic Leukemia, Myeloblastic Leukemia, Biphenotypic Acute Leukemia Trial (GVHD prevention: post-transplantation
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +5 more
- GVHD prevention: post-transplantation cyclophosphamide, abatacept, vedolizumab, calcineurin inhibitor
- (no location specified)
Aug 23, 2022
Hematopoietic Organs; Disorder Trial in Hong Kong (CD62L depleted donor lymphocyte infusion)
Recruiting
- Hematopoietic Organs; Disorder
- CD62L depleted donor lymphocyte infusion
-
Hong Kong, Hong KongHong Kong Children's Hospital
Sep 6, 2023
Hematopoietic Organs; Disorder Trial in Hong Kong (Total lymphoid irradiation)
Recruiting
- Hematopoietic Organs; Disorder
- Total lymphoid irradiation
-
Hong Kong, Hong KongHong Kong Children's Hospital
Oct 4, 2023
DiGeorge Anomaly Trial (Serum Free Thymus Transplantation with Immunosuppression, Serum Free Thymus Transplantation without
Terminated
- DiGeorge Anomaly
- Serum Free Thymus Transplantation with Immunosuppression
- Serum Free Thymus Transplantation without immunosuppression
- (no location specified)
Mar 21, 2022
DiGeorge Syndrome, DiGeorge Anomaly, Complete DiGeorge Anomaly Trial in Durham (Thymus Tissue for Transplantation)
Completed
- DiGeorge Syndrome
- +3 more
- Thymus Tissue for Transplantation
-
Durham, North CarolinaDuke University Medical Center
Mar 23, 2022
Complete DiGeorge Anomaly, DiGeorge Syndrome, DiGeorge Anomaly Trial in Durham (biological, procedure, drug)
Approved for marketing
- Complete DiGeorge Anomaly
- +3 more
- Cultured Thymus Tissue
- +6 more
-
Durham, North CarolinaJohn W. Sleasman
Mar 21, 2022
DiGeorge Anomaly, Complete DiGeorge Anomaly, Complete Atypical DiGeorge Anomaly Trial in Durham (biological, other, procedure,
Completed
- DiGeorge Anomaly
- +4 more
- Cultured Thymus Tissue for Implantation (CTTI)
- +8 more
-
Durham, North CarolinaDuke University Medical Center
Mar 23, 2022
Acute Leukemia (Category) Trial in Worldwide (HSV-Tk, T-cell depleted or T-cell replete strategies)
Terminated
- Acute Leukemia (Category)
- HSV-Tk
- T-cell depleted or T-cell replete strategies
-
Chicago, Illinois
- +35 more
Jun 1, 2021
Cytomegalovirus Infection, Adenovirus Infection Trial in Vienna (virus-specific T-Cells)
Withdrawn
- Cytomegalovirus Infection
- Adenovirus Infection
- virus-specific T-Cells
-
Vienna, AustriaSt. Anna Children's Hospital
May 7, 2019
Malignant and Non-malignant High Risk Diseases Trial in Frankfurt am Main (Hematopoietic stem cell product from haploidentical
Terminated
- Malignant and Non-malignant High Risk Diseases
- Hematopoietic stem cell product from haploidentical or unrelated donor CD3/CD19 depleted with CliniMACS
-
Frankfurt am Main, Hessen, GermanyUniversity Hospital Frankfurt, Dept. for Children and Adolescent
Aug 13, 2018
Chinese Network of Pediatric Antiretroviral Therapy
Completed
- Acquired Immunodeficiency Syndrome
-
Beijing, ChinaNational Center for AIDS/STD Control and Prevention, China Cente
Mar 28, 2018
Non-Hodgkin Lymphoma Trial in Germany (Radioimmunotherapy, allogeneic hematopoietic cell transplantation)
Completed
- Non-Hodgkin Lymphoma
- Radioimmunotherapy
- allogeneic hematopoietic cell transplantation
-
Berlin, Germany
- +10 more
May 28, 2014
Leukemia Trial in New York (biological, drug, procedure, radiation)
Completed
- Leukemia
- anti-thymocyte globulin
- +8 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jun 24, 2013
Immunologic Deficiency Syndromes, Chediak-Higashi Syndrome, Common Variable Immunodeficiency Trial in Minneapolis
Terminated
- Immunologic Deficiency Syndromes
- +13 more
- anti-thymocyte globulin
- +8 more
-
Minneapolis, MinnesotaFairview University Medical Center
Oct 14, 2009
HIV Infection Trial run by the NCI (Ritonavir, Nevirapine, Stavudine)
Completed
- HIV Infection
- Ritonavir
- +2 more
-
Bethesda, MarylandNational Cancer Institute (NCI)
Mar 3, 2008
HIV-Infected Children Receiving Protease Inhibitor and Reverse
Completed
- HIV Infection
-
Bethesda, MarylandNational Cancer Institute (NCI)
Mar 3, 2008
HIV Trial run by the NCI (Eye exam, Oral exam, CT scan)
Completed
- HIV Infections
- Eye exam
- +5 more
-
Bethesda, MarylandNational Cancer Institute (NCI)
Mar 3, 2008